Covid: GSK says tests show antibody drug works against Omicron variant
Laboratory examination of the antibody-based mostly Covid-19 treatment GlaxoSmithKline (GSK) is producing with US partner
Laboratory examination of the antibody-based mostly Covid-19 treatment GlaxoSmithKline (GSK) is producing with US partner